Artificial Intelligence-Assisted Training for Novice Physicians in Electronic Nasopharyngolaryngoscopy
Application of an Artificial Intelligence-Assisted Monitoring System for Electronic Nasopharyngolaryngoscopy in the Training of Novice Physicians: A Prospective, Single-Center, Randomized Controlled Study
1 other identifier
interventional
138
1 country
1
Brief Summary
This study aims to evaluate whether an artificial intelligence-assisted monitoring system can improve the training of novice physicians in electronic nasopharyngolaryngoscopy. The study will compare AI-assisted training with conventional training in terms of post-training examination performance.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Jul 2026
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
July 1, 2026
CompletedStudy Start
First participant enrolled
July 1, 2026
CompletedFirst Posted
Study publicly available on registry
July 24, 2026
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 31, 2026
ExpectedStudy Completion
Last participant's last visit for all outcomes
February 28, 2027
July 24, 2026
June 1, 2026
6 months
July 1, 2026
July 21, 2026
Conditions
Outcome Measures
Primary Outcomes (1)
Post-training procedural performance score
Each post-training procedure will be video recorded and assessed by blinded expert raters using Flexible Pharyngo-Laryngoscopy Assessment Tool (FLEXPAT). The scale includes 9 mandatory items, each scored from 1 to 5, with a total score ranging from 9 to 45 points. A higher score indicates better procedural performance.
During each post-training assessment procedure.
Secondary Outcomes (5)
Anatomical Site Coverage Rate
During each post-training assessment procedure.
Examination Time
During each post-training assessment procedure.
Image Quality Score
During each post-training assessment procedure.
Patient Comfort
Immediately after or during each post-training assessment procedure.
Trainee Satisfaction with the AI System
Within 2 weeks after completion of the training phase
Study Arms (2)
AI-Assisted Training Group
EXPERIMENTALNovice physicians in this group will receive additional assistance from an AI-assisted monitoring system during electronic nasopharyngolaryngoscopy training. The AI system provides real-time monitoring and visual prompts for anatomical site coverage during the examination.
Conventional Training Group
NO INTERVENTIONNovice physicians in this group will receive conventional theoretical and practical training in electronic nasopharyngolaryngoscopy without real-time AI assistance during training.
Interventions
The AI-assisted monitoring system analyzes electronic nasopharyngolaryngoscopy video in real time and provides prompts regarding anatomical sites that have been examined. Examined anatomical sites are displayed on the screen, and the system provides information such as examination time and number of anatomical sites covered. The system is used as an adjunctive training tool and does not replace the clinical judgment of supervising physicians.
Eligibility Criteria
You may qualify if:
- Aged 18 years or older.
- Otorhinolaryngology residents or standardized residency training physicians.
- No prior independent experience in electronic nasopharyngolaryngoscopy.
- Holding both a physician qualification certificate and a physician practice certificate registered at the study institution.
You may not qualify if:
- Previous participation in other endoscopy training studies.
- Inability to complete the required continuous training period
- Aged 18 years or older.
- Male or female.
- Clinical need for electronic nasopharyngolaryngoscopy.
- Pregnancy.
- History of allergy to topical anesthetics such as tetracaine or lidocaine.
- Language or communication barriers.
- Anatomical abnormalities, such as laryngeal stenosis, or prior nasopharyngeal or laryngeal surgery.
- Inability to tolerate the examination position.
- Any condition judged by the investigator to make the participant unsuitable for the study.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Ruijin Hospitallead
Study Sites (1)
Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai
Shanghai, China
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- OUTCOMES ASSESSOR
- Purpose
- OTHER
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
July 1, 2026
First Posted
July 24, 2026
Study Start
July 1, 2026
Primary Completion (Estimated)
December 31, 2026
Study Completion (Estimated)
February 28, 2027
Last Updated
July 24, 2026
Record last verified: 2026-06
Data Sharing
- IPD Sharing
- Will not share
Individual participant data will not be shared publicly. The study involves clinical and endoscopic video data collected from patients, which may contain sensitive medical information. Due to privacy protection, ethical requirements, and institutional data governance policies, de-identified individual participant data will not be made available outside the research team.